Benefits and safety of myomectomy during cesarean section
Downloads
HIGHLIGHTS
1. Myomectomy during cesarean section is a recommended and safe procedure.
2. This procedure benefits the patient because it avoids a second operation and anesthesia complications and is cost-saving.
ABSTRACT
Uterine myoma is a tumor in the uterus that is generally benign. There are many types of uterine myomas. These tumors can grow on the outer wall of the uterus, on the uterine muscle, or it can also be on the inner wall of the uterus. The most frequent kind of uterine tumor is myoma. Uterine myoma mostly occurs in women over thirty years of age. Its prevalence ranges from 5.4% to 77%, with uterine fibroids accounting for up to 5% of pregnancies. The myomectomy procedure is an option for women who still want children but are concerned about the possibility of subsequent surgical intervention. The myomectomy cesarean section is indicated if there were complications related to the myoma in a previous pregnancy. It also avoids the possibility of repeat laparotomy for fibroid removal in the future. Myomectomy surgery should be planned based on fibroids' location, size, and quantity, using suitable imaging. Myomectomy cesarean section can be an option compared to cesarean section without myomectomy, especially if it is performed by experienced surgeons with proper hemostatic techniques and performed in tertiary-level health facilities. This article discusses the details of the benefits and safety of myomectomy during cesarean section so that it might be considered before performing this procedure.
Sparic R, Mirkovic L, Malvasi A, et al. Epidemiology of uterine myomas: A review. Int J Fertil Steril. 2016;9(4):424-35. doi: 10.22074/ijfs. 2015.4599. Epub 2015 Dec 23. PMID: 26985330; PMCID: PMC4793163.
Sparic R, Terzic M, Malvasi A, Tinelli A. Uterine fibroids - clinical presentation and complications. Acta Chir Iugosl. 2014;61(3):41–8. doi: 10.2298/ ACI1403041S.
Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. PMID: 31960950.
Sparic R, Nejkovic L, Mutavdzic D, et al. Conservative surgical treatment of uterine fibroids. Acta Chir Iugosl. 2014;61(4):11–6. doi: 10.2298/ ACI1404011S.
Sparić R. [Uterine myomas in pregnancy, childbirth and puerperium]. Srp Arh Celok Lek. 2014;142(1-2):118-24. Serbian. doi: 10.2298/sarh1402118s. PMID: 24684044.
Malvasi A, Stark M, Tinelli A. Cesarean myomectomy. In: Uterine myoma, myomectomy and minimally invasive treatments. 1st ed. Berlin: Springer; 2015. p. 237–52.
Sakinci M, Turan G, Sanhal CY, et al. Analysis of myomectomy during cesarean section: A tertiary center experience. J Invest Surg. 2022;35(1):23-9. doi: 10.1080/08941939.2020.1810832. Epub 2020 Aug 30. PMID: 32865048.
Kumar RR, Patil M, Sa S. The utility of caesarean myomectomy as a safe procedure: a retrospective analysis of 21 cases with review of literature. J Clin Diagn Res. 2014;8(9):OC05-8. doi: 10.7860/JCDR/ 2014/8630.4795. Epub 2014 Sep 20. PMID: 25386485; PMCID: PMC4225937.
Sparić R, Malvasi A, Tinelli A. Analysis of clinical, biological and obstetric factors influencing the decision to perform cesarean myomectomy. Ginekol Pol. 2015;86(1):40-5. doi: 10.17772/gp/ 1897. PMID: 25775874.
Kwon DH, Song JE, Yoon KR, et al. The safety of cesarean myomectomy in women with large myomas. Obstet Gynecol Sci. 2014;57(5):367-72. doi: 10.5468/ogs.2014.57.5.367. Epub 2014 Sep 17. PMID: 25264526; PMCID: PMC4175596.
Ramya T, Sabnis SS, Chitra TV, et al. Cesarean myomectomy: An experience from a tertiary care teaching hospital. J Obstet Gynaecol India. 2019; 69(5):426-30. doi: 10.1007/s13224-019-01239-x. Epub 2019 Jun 3. PMID: 31598045; PMCID: PMC6765039.
Sparic R, Stamenkovic J, Nejkovic L, et al. When it is oportune to avoid cesarean myomectomy? An analysis of possible factors influencing duration of treatment in the intensive care unit. Acta Chir Iugosl. 2015;62(2):71–6. doi: 10.2298/ACI150 2071S.
Spariç R. Intraoperative hemorrhage as a complication of cesarean myomectomy: Analysis of risk factors. Vojnosanit Pregl. 2016;73(5):415-21. doi: 10.2298/vsp141105029s. PMID: 27430104.
Pattanaik T, Pati B, Samal S. Caesarean myomec-tomy: a descriptive study of clinical outcome. Int J Reprod Contraception, Obstet Gynecol. 2014;3(1): 172–4. doi: 10.5455/2320-1770.ijrcog20140334
Åžükür YE, Kankaya D, Ateş C, et al. Clinical and histopathologic predictors of reoperation due to recurrence of leiomyoma after laparotomic myomectomy. Int J Gynaecol Obstet. 2015;129(1):75-8. doi: 10.1016/j.ijgo.2014.10.023. Epub 2014 Dec 17. PMID: 25541504.
Huang Y, Ming X, Li Z. Feasibility and safety of performing cesarean myomectomy: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2022;35(13):2619-27. doi: 10.1080/14767 058.2020.1791816. Epub 2020 Jul 16. PMID: 32674632.
Society of Obstetricians and Gynaecologists of Canada. The Society of Obstetricians and Gynaecologists of Canada. 2022.
Milazzo GN, Catalano A, Badia V, et al. Myoma and myomectomy: Poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43(12): 1789-1804. doi: 10.1111/jog.13437. Epub 2017 Sep 11. PMID: 28892210.
Sarais V, Cermisoni GC, Schimberni M, et al. Human chorionic gonadotrophin as a possible mediator of leiomyoma growth during pregnancy: Molecular mechanisms. Int J Mol Sci. 2017; 18(9):2014. doi: 10.3390/ijms18092014. PMID: 28930160; PMCID: PMC5618662.
Tokgöz C, Hatirnaz Åž, Güler O. Pros and cons of myomectomy during cesarean section [Internet]. Caesarean Section. InTech; 2018. Available from: http://dx.doi.org/10.5772/intechopen.75365.
Guler AE, Guler ZÇD, Kinci MF, Mungan MT. Myomectomy During Cesarean Section: Why Do We Abstain From? J Obstet Gynecol India [Internet]. 2020;70(2):133–7. Available from: https://doi.org/10.1007/s13224-019-01303-6.
Eyong E, Okon OA. Large uterine fibroids in pregnancy with successful caesarean myomectomy. Case Rep Obstet Gynecol. 2020;2020:8880296. doi: 10.1155/2020/8880296. PMID: 33224543; PMCID: PMC7671803.
Senturk MB, Polat M, Doğan O, et al. Outcome of cesarean myomectomy: Is it a safe procedure? Geburtshilfe Frauenheilkd. 2017;77(11):1200-6. doi: 10.1055/s-0043-120918. Epub 2017 Nov 27. PMID: 29200476; PMCID: PMC5703655.
El-Refaie W, Hassan M, Abdelhafez MS. Myomec-tomy during cesarean section: A retrospective cohort study. J Gynecol Obstet Hum Reprod. 2020:101900. doi: 10.1016/j.jogoh.2020.101900. Epub ahead of print. PMID: 32860969.
Goyal M, Dawood AS, Elbohoty SB, et al. Cesarean myomectomy in the last ten years; A true shift from contraindication to indication: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;256:145-57. doi: 10.1016/j.ejogrb.2020.11.008. Epub 2020 Nov 11. PMID: 33232889.
Sparić R, Kadija S, Stefanović A, et al. Cesarean myomectomy in modern obstetrics: More light and fewer shadows. J Obstet Gynaecol Res. 2017;43(5): 798-804. doi: 10.1111/jog.13294. Epub 2017 Feb 7. PMID: 28168805.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.